Interpretation of Autoimmune Neurological Antibody Profiles
This program is worth up to 1.0 CME credits.
This course will impart some basic immunological principles and antibody nomenclature that will help with interpretation of autoimmune neurological antibody test results. This will aid accurate neurological and oncological diagnoses, appropriate selection of immunotherapies and prognostication.
Up to 1.0 CME credit
*Free access is limited to one course at a time for eligible members.
As a result of this program the learner will:
Apply basic immunological principles in clinical practice to areas including cancer testing, immunotherapy, and prognostication. This will be achieved by breaking the activity into four elements, the first of which will be a broad overview of the topic, followed by more detail regarding neuronal nuclear and cytoplasmic antibodies and plasma membrane protein antibodies, followed by cases.
- Patient Care
- Medical Knowledge
Date of Release
April 22, 2015
This module is eligible for CME credits for three years from the release date.
Confidentiality of Data
All material © American Academy of Neurology Institute unless otherwise indicated. All rights reserved.
Faculty & Disclosures
Andrew McKeon, MD
Mayo Clinic, Rochester, MN
*Dr. McKeon has received research support from MedImmune for a laboratory diagnostics study.
A. GORDON SMITH, MD, FAAN
University of Utah Department of Neurology
Salt Lake City, Utah
*Dr. Smith has received personal compensation for activities with Allergan, Baxter Bioscience, Merz, Pfizer and NeurogesX as a consultant..
Tracy King, MA, Associate Director, Education
*Ms. King has nothing to disclose.
Maureen Holtzman, Program Manager, Online Learning
*Ms. Holtzman has nothing to disclose.
Robert Rook, Program Manager, Digital Education Resources
*Mr. Rook has nothing to disclose.
Susan Rodmyre, Senior Director, Education
*Ms. Rodmyre has nothing to disclose.
Kurt Wiersma, Senior Manager, Web Development
*Mr. Wiersma has nothing to disclose.